Heubach Colorants India Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Heubach Colorants India.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Chemicals earnings growth | 20.9% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
What Heubach Colorants India Limited's (NSE:HEUBACHIND) 26% Share Price Gain Is Not Telling You
Oct 12Is Heubach Colorants India (NSE:HEUBACHIND) A Risky Investment?
Oct 01Heubach Colorants India Limited (NSE:HEUBACHIND) Surges 29% Yet Its Low P/E Is No Reason For Excitement
Jun 22Here's Why Heubach Colorants India (NSE:HEUBACHIND) Can Manage Its Debt Responsibly
Feb 09A Look At The Intrinsic Value Of Clariant Chemicals (India) Limited (NSE:CLNINDIA)
Nov 16Shareholders May Not Be So Generous With Clariant Chemicals (India) Limited's (NSE:CLNINDIA) CEO Compensation And Here's Why
Aug 05Calculating The Intrinsic Value Of Clariant Chemicals (India) Limited (NSE:CLNINDIA)
Mar 10What Type Of Shareholders Own The Most Number of Clariant Chemicals (India) Limited (NSE:CLNINDIA) Shares?
Feb 12Is Clariant Chemicals (India) Limited's (NSE:CLNINDIA) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Jan 25Is Clariant Chemicals (India) Limited's (NSE:CLNINDIA) 2.9% Dividend Worth Your Time?
Jan 08Clariant Chemicals (India)'s (NSE:CLNINDIA) Earnings Are Growing But Is There More To The Story?
Dec 21A Look At Clariant Chemicals (India)'s (NSE:CLNINDIA) CEO Remuneration
Dec 02Reflecting on Clariant Chemicals (India)'s(NSE:CLNINDIA) Total Shareholder Returns Over The Last Five Years
Nov 14Weak Financial Prospects Seem To Be Dragging Down Clariant Chemicals (India) Limited (NSE:CLNINDIA) Stock
Oct 24Factors Income Investors Should Consider Before Adding Clariant Chemicals (India) Limited (NSE:CLNINDIA) To Their Portfolio
Oct 01What Kind Of Shareholders Own Clariant Chemicals (India) Limited (NSE:CLNINDIA)?
Sep 14How Does Clariant Chemicals (India)'s (NSE:CLNINDIA) CEO Salary Compare to Peers?
Aug 27Don't Buy Clariant Chemicals (India) Limited (NSE:CLNINDIA) For Its Next Dividend Without Doing These Checks
Aug 12Don't Race Out To Buy Clariant Chemicals (India) Limited (NSE:CLNINDIA) Just Because It's Going Ex-Dividend
Aug 12Clariant Chemicals (India) Limited's (NSE:CLNINDIA) Popularity With Investors Under Threat
Aug 12Clariant Chemicals (India) (NSE:CLNINDIA) Has Returned Negative 23% To Its Shareholders In The Past Five Years
Aug 10Clariant Chemicals (India) Limited's (NSE:CLNINDIA) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?
Jul 26Is Clariant Chemicals (India) Limited (NSE:CLNINDIA) A Good Dividend Stock?
Jun 28In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Heubach Colorants India has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2024 | 7,547 | 303 | N/A | N/A | N/A |
3/31/2024 | 7,907 | 411 | 780 | 945 | N/A |
12/31/2023 | 7,654 | 445 | N/A | N/A | N/A |
9/30/2023 | 7,676 | 449 | -57 | 117 | N/A |
6/30/2023 | 7,557 | 242 | N/A | N/A | N/A |
3/31/2023 | 7,664 | 192 | 200 | 363 | N/A |
12/31/2022 | 7,968 | 261 | N/A | N/A | N/A |
9/30/2022 | 8,404 | 279 | 273 | 444 | N/A |
6/30/2022 | 8,468 | 399 | N/A | N/A | N/A |
3/31/2022 | 8,395 | 433 | -70 | 131 | N/A |
12/31/2021 | 8,483 | 381 | N/A | N/A | N/A |
9/30/2021 | 8,286 | 428 | 159 | 356 | N/A |
6/30/2021 | 8,145 | 2,303 | N/A | N/A | N/A |
3/31/2021 | 7,308 | 2,187 | 471 | 567 | N/A |
12/31/2020 | 6,814 | 2,081 | N/A | N/A | N/A |
9/30/2020 | 6,676 | 1,981 | 720 | 780 | N/A |
6/30/2020 | 6,765 | 155 | N/A | N/A | N/A |
3/31/2020 | 7,573 | 186 | 765 | 1,011 | N/A |
12/31/2019 | 10,821 | 306 | N/A | N/A | N/A |
9/30/2019 | 10,753 | 299 | 242 | 624 | N/A |
6/30/2019 | 10,596 | 202 | N/A | N/A | N/A |
3/31/2019 | 7,188 | 115 | -29 | 294 | N/A |
12/31/2018 | 10,142 | 124 | N/A | N/A | N/A |
9/30/2018 | 10,270 | 319 | N/A | N/A | N/A |
6/30/2018 | 10,148 | 327 | N/A | N/A | N/A |
3/31/2018 | 10,136 | 216 | N/A | -11 | N/A |
12/31/2017 | 10,241 | 276 | N/A | N/A | N/A |
9/30/2017 | 9,935 | 100 | N/A | N/A | N/A |
6/30/2017 | 9,844 | 90 | N/A | N/A | N/A |
3/31/2017 | 9,810 | 245 | N/A | 816 | N/A |
12/31/2016 | 9,335 | -25 | N/A | N/A | N/A |
9/30/2016 | 9,320 | 59 | N/A | N/A | N/A |
6/30/2016 | 9,262 | 273 | N/A | N/A | N/A |
3/31/2016 | 9,060 | 303 | N/A | -1,187 | N/A |
12/31/2015 | 9,291 | 430 | N/A | N/A | N/A |
9/30/2015 | 8,327 | 8,730 | N/A | N/A | N/A |
6/30/2015 | 8,588 | 8,502 | N/A | N/A | N/A |
3/31/2015 | 8,970 | 9,312 | N/A | N/A | N/A |
12/31/2014 | 8,547 | 8,361 | N/A | -597 | N/A |
9/30/2014 | 5,041 | 564 | N/A | N/A | N/A |
6/30/2014 | 6,033 | 1,817 | N/A | N/A | N/A |
3/31/2014 | 6,578 | 1,204 | N/A | N/A | N/A |
12/31/2013 | 6,835 | 1,312 | N/A | -318 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if HEUBACHIND's forecast earnings growth is above the savings rate (6.7%).
Earnings vs Market: Insufficient data to determine if HEUBACHIND's earnings are forecast to grow faster than the Indian market
High Growth Earnings: Insufficient data to determine if HEUBACHIND's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if HEUBACHIND's revenue is forecast to grow faster than the Indian market.
High Growth Revenue: Insufficient data to determine if HEUBACHIND's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if HEUBACHIND's Return on Equity is forecast to be high in 3 years time